Home > News > Novel Gene Therapy Effectively Reduces Asthma Symptoms in Mice
October 31st, 2003
Novel Gene Therapy Effectively Reduces Asthma Symptoms in Mice
A novel nasal spray containing minuscule particles that deliver therapeutic protein-producing genes effectively reduces allergen-induced airway inflammation and hyper-reactivity, the hallmark symptoms of asthma. "By treating asthmatic mice with this gene therapy, we have allowed their lungs to produce the protein, interferon gamma, that is needed to reduce asthmatic symptoms," said Shyam S. Mohapatra, PhD, principal investigator. Mohapatra and his team selected chitosan nanoparticles as a delivery method for interferon gamma gene.
Vegetable oil ingredient key to destroying gastric disease bacteria: In mice, therapeutic nanoparticles dampen H. pylori bacteria and inflammation that lead to ulcers and gastric cancer November 25th, 2014
Research reveals how our bodies keep unwelcome visitors out of cell nuclei November 24th, 2014
ASU, IBM move ultrafast, low-cost DNA sequencing technology a step closer to reality November 24th, 2014
An Inside Job: UC-Designed Nanoparticles Infiltrate, Kill Cancer Cells From Within November 24th, 2014